PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a
2017 · Journal of Experimental & Clinical Cancer Research · 88 citations
https://doi.org/10.1186/s13046-017-0593-2
L
Lijuan Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
2.0K
Citations
21
h-index
41
i10-index
Lijuan Zhang is an academic researcher from Nanjing University of Chinese Medicine. The author has contributed to research in topics: Cancer-related molecular mechanisms research & RNA modifications and cancer & MicroRNA in disease regulation. The author has an h-index of 21, co-authored 99 publications.
ORCID: 0000-0001-6857-3647Papers by this author
worksHNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis
2023 · Journal of Translational Medicine · 57 citations
https://doi.org/10.1186/s12967-023-04190-8
LncRNA PVT1 promotes the growth of HPV positive and negative cervical squamous cell carcinoma by inhibiting TGF-β1
2018 · Cancer Cell International · 51 citations
https://doi.org/10.1186/s12935-018-0567-2
miR‐200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer
2019 · Journal of Cellular and Molecular Medicine · 42 citations
https://doi.org/10.1111/jcmm.14681
Upregulated long-non-coding RNA DLEU2 exon 9 expression was an independent indicator of unfavorable overall survival in patients with esophageal adenocarcinoma
2019 · Biomedicine & Pharmacotherapy · 20 citations
https://doi.org/10.1016/j.biopha.2019.108655
Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer
2018 · Current Cancer Drug Targets · 14 citations
https://doi.org/10.2174/1568009618666180709163718
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat